Category Archives: Institute

FAST & Fellows Round Up

August 2017 Read the latest in FAST and Fellows news: CLSA Fellow Enable Biosciences wins Amgen Golden Ticket at QB3@953 | Read More News about CLSA Fellow Meissa Vaccines: $1.6m Fast Track SBIR grant for RSV vaccine candidate | Read More Seed round investment from FundRx | Read More To learn more about the CLSA Fellows program – the … Continue reading FAST & Fellows Round Up

CARB-X Brings the San Diego AMR Community Together-Testimonials

To view the original article, click here. “This was a well-organized and executed event to help introduce and educate prospective applicants on the CARB-X funding mechanism. Including two guest speakers from exemplary programs funded by CARB-X provided great value to better understand the process and type of science being targeted. The additional opportunity to network … Continue reading CARB-X Brings the San Diego AMR Community Together-Testimonials

NexGeneGirls Bootcamp and Summer Science Academy Celebration

The 2017 NexGeneGirls Bootcamp and Summer Science Academy concluded with a gala event and poster presentation at UCSF Mission Bay on July 27th.  In addition to congratulatory remarks by the Honorable Edwin M. Lee, Mayor of San Francisco, the program included a keynote address by Dr. Joy L. Hightower, from Genentech’s Innovation, Diversity & Inclusion … Continue reading NexGeneGirls Bootcamp and Summer Science Academy Celebration

Recent News from Powered by CARB-X Companies

Forge Therapeutics announced the formation of a Scientific Advisory Board with world renowned antibiotic and drug development experts. Read More Tetraphase Pharmaceuticals announced top-line Phase 3 data for complicated intra-abdominal infections. Read More Cidara Therapeutics announced publication of results from an in vivo study of its novel antifungal candidate CD101. Read More In welcome funding … Continue reading Recent News from Powered by CARB-X Companies

Introducing the Fall 2017 FAST Companies

Eight life science startups, vetted and selected by a distinguished review panel, have been selected for CLSI’s Fall 2017 Fellows All-Star Team (FAST) Advisory Program. The Fall 2017 FAST companies are: BioAmp Diagnostics, developing diagnostic tools that decrease the time-to-results for identification of bacterial infections from 3 days to 30 minutes using an innovative amplification … Continue reading Introducing the Fall 2017 FAST Companies

CARB-X Brings the San Diego AMR Community Together

On Tuesday July 18, CARB-X, one of the world’s largest public private partnerships focused on combating antimicrobial resistance (AMR), held a standing-room only event at BioLabs in San Diego. The purpose of the event was to: (1) bring together the antimicrobial resistance community in the greater San Diego area; (2) provide information about the mission … Continue reading CARB-X Brings the San Diego AMR Community Together

CLSI Partner NexGeneGirls featured in first Genentech “Communities” Video Series

NexGeneGirls founder and Scientific Researcher at Genentech, Marlena Jackson, is featured in the first video in Genentech’s “Communities” series: What Does a Scientist Look Like?  The series is intended to highlight remarkable employee services to the community.  While an employee of Genentech, Ms. Jackson founded NexGeneGirls in 2011 to provide opportunities in STEM fields to young females … Continue reading CLSI Partner NexGeneGirls featured in first Genentech “Communities” Video Series

Bio-Link Depot

Tax-Deductible Equipment, Supply & Consumable Donations Northern California companies can make tax deductible donations of equipment, supplies and consumables – giving them a second life in cash-starved classrooms – through the Bio-Link Depot, which is moving to Oakland on September 1, 2017. The Depot accepts high caliber equipment and supplies from donating entities and makes … Continue reading Bio-Link Depot

Biotech Primer article: Meds for Thinner Blood Can Equal Fewer Clots, But How?

STOPPING A BIG PROBLEM: BLOOD CLOTS In Cocktail Fodder, Drug Approvals, Drug Targets, Mechanism of Action, Small Molecule Drugs by Emily Burke July 13, 2017 Original article can be found here. MEDS FOR THINNER BLOOD CAN EQUAL FEWER CLOTS, BUT HOW? The FDA’s recent approval of Portola Pharmaceuticals’ (South San Francisco, CA) new blood thinner drug Bevyxxa paved the way for the prevention of blood clots in … Continue reading Biotech Primer article: Meds for Thinner Blood Can Equal Fewer Clots, But How?

Spring 2017 FAST Closing Showcase Celebrates Seven Companies

CLSI celebrated key milestones at the Spring 2017 FAST Closing Showcase at UCSF’s Byers Auditorium on June 13.  The Showcase marked the culmination of the Spring program and included presentations from seven graduating FAST companies: Encellin, an innovative ultra thin-film cell delivery platform company; LogicInk, developing programmable temporary tattoos that are electronics-free and transform to convey … Continue reading Spring 2017 FAST Closing Showcase Celebrates Seven Companies